Moreover, heterozygous mutations of EMX2 in humans have been implicated in some cases of a rare developmental disorder, schizencephaly, characterized by different clinical features, including mental retardation, hypotonia, epilepsy and spasticity [11,12]. Here, EMX2 is linked to schizencephaly.